139 related articles for article (PubMed ID: 18710384)
1. Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.
Cervetti G; Galimberti S; Andreazzoli F; Fazzi R; Cecconi N; Caracciolo F; Petrini M
Br J Haematol; 2008 Oct; 143(2):296-8. PubMed ID: 18710384
[No Abstract] [Full Text] [Related]
2. Rituximab as treatment for minimal residual disease in hairy cell leukaemia.
Cervetti G; Galimberti S; Andreazzoli F; Fazzi R; Cecconi N; Caracciolo F; Petrini M
Eur J Haematol; 2004 Dec; 73(6):412-7. PubMed ID: 15522063
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).
Zenhäusern R; Simcock M; Gratwohl A; Hess U; Bargetzi M; Tobler A;
Haematologica; 2008 Sep; 93(9):1426-8. PubMed ID: 18603561
[No Abstract] [Full Text] [Related]
4. [Complete remission after Rituximab treatment in refractory hairy cell leukemia].
Petruskevicius I; Bukh A; Mertz H; Johnsen HE
Ugeskr Laeger; 2008 Jun; 170(26-32):2350. PubMed ID: 18570771
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of rituximab in anti-mag polyneuropathy.
Benedetti L; Briani C; Franciotta D; Carpo M; Padua L; Zara G; Zambello R; Sormani MP; Mancardi GL; Nobile-Orazio E; Schenone A
Neurology; 2008 Nov; 71(21):1742-4. PubMed ID: 19015493
[No Abstract] [Full Text] [Related]
6. Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia.
Thachil J; Mukherje K; Woodcock B
Br J Haematol; 2006 Oct; 135(2):273-4. PubMed ID: 16965386
[No Abstract] [Full Text] [Related]
7. Monoclonal antibody therapy for hairy cell leukemia.
Thomas DA; Ravandi F; Kantarjian H
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1125-36. PubMed ID: 16990112
[TBL] [Abstract][Full Text] [Related]
8. 2-CdA in the treatment of hairy cell leukaemia.
Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
[TBL] [Abstract][Full Text] [Related]
9. [Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis].
Milovanova SIu; Lopatkina TN; Kozlovskaia LV; Krasnova TN
Ter Arkh; 2007; 79(6):69-72. PubMed ID: 17684972
[No Abstract] [Full Text] [Related]
10. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
Jacob A; Weinshenker BG; Violich I; McLinskey N; Krupp L; Fox RJ; Wingerchuk DM; Boggild M; Constantinescu CS; Miller A; De Angelis T; Matiello M; Cree BA
Arch Neurol; 2008 Nov; 65(11):1443-8. PubMed ID: 18779415
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for treatment of ocular inflammatory disease: a series of four cases.
Kurz PA; Suhler EB; Choi D; Rosenbaum JT
Br J Ophthalmol; 2009 Apr; 93(4):546-8. PubMed ID: 19321476
[TBL] [Abstract][Full Text] [Related]
12. Rituximab treatment of mild haemophilia A with inhibitors: a proposed treatment protocol.
Dunkley S; Kershaw G; Young G; Warburton P; Lindeman R; Matthews S; Rennisson F
Haemophilia; 2006 Nov; 12(6):663-7. PubMed ID: 17083518
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of recalcitrant pemphigus foliaceus with rituximab.
Serrão VV; Martins A; Páris FR; Lopes MP
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):768-70. PubMed ID: 18482042
[No Abstract] [Full Text] [Related]
14. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
15. Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab.
Angelopoulou MK; Pangalis GA; Sachanas S; Kokoris SI; Anargyrou K; Galani Z; Kalpadakis C; Vassilakopoulos TP
Leuk Lymphoma; 2008 Sep; 49(9):1817-20. PubMed ID: 18798112
[No Abstract] [Full Text] [Related]
16. Rituximab treatment of fibrillary glomerulonephritis.
Collins M; Navaneethan SD; Chung M; Sloand J; Goldman B; Appel G; Rovin BH
Am J Kidney Dis; 2008 Dec; 52(6):1158-62. PubMed ID: 18823685
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report.
Vischini G; Cudillo L; Ferrannini M; Di Daniele N; Cerretti R; Arcese W
J Nephrol; 2009; 22(1):160-3. PubMed ID: 19229832
[TBL] [Abstract][Full Text] [Related]
18. Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
Hofstra JM; Deegens JK; Wetzels JF
Nephrol Dial Transplant; 2007 Jul; 22(7):2100-2. PubMed ID: 17389619
[No Abstract] [Full Text] [Related]
19. Efficacy of rituximab in hairy cell leukemia treatment.
Zinzani PL; Ascani S; Piccaluga PP; Bendandi M; Pileri S; Tura S
J Clin Oncol; 2000 Nov; 18(22):3875-7. PubMed ID: 11078503
[No Abstract] [Full Text] [Related]
20. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
